(2019) Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticuiate systems as a novel intranasal pertussis vaccine. Artificial Cells Nanomedicine and Biotechnology. pp. 2605-2611. ISSN 2169-1401

(2018) Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model. Vaccine. pp. 2886-2895. ISSN 0264-410X

(2017) Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen. Artificial Cells Nanomedicine and Biotechnology. pp. 291-296. ISSN 2169-1401

(2015) A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 enhances cell-mediated immune response and longevity of the total IgG to influenza A virus M2e protein in mice. Antiviral Research. pp. 23-31. ISSN 0166-3542

(2014) Vaccination with recombinant 4 x M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens. Veterinary Microbiology. pp. 116-126. ISSN 0378-1135

(2012) Expression of recombinant HAO3 from an Iranian isolate of Hyalomma anatolicum anatolicum in Pichia pastoris and evaluation of its antigenicity. Biologicals. pp. 72-78. ISSN 1045-1056

(2012) In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of Hi, H3 and H9 influenza A isolates circulating in Iran. Virology. pp. 63-72. ISSN 0042-6822

(2012) In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine. Virus Research. pp. 219-225. ISSN 0168-1702